Interferon alpha-2b biosimilar (Axxo)

干扰素α-2b生物类似药（Axxo）

Report date: 2022/01/24 16:44:03

Base Information

Drug NameInterferon alpha-2b biosimilar (Axxo)
Drug Alias Name干扰素α-2b生物仿制药（Axxo）
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsLeukemiaHepatitis CHepatitis B +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAxxo
China Registration ClassN/A

Develop Information

Active CompaniesAxxo
Inactive CompaniesN/A
Active IndicationsLeukemiaHepatitis CHepatitis B +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeL03AB05
Related LinksN/A